MBL

MBL was established in 1969 in Japan, and concentrated on the development and production of immunological diagnostic reagents, especially for collagen diseases and autoimmune diseases.

In 1993, MBL International was established in Massachusetts, USA. MBL International manufactures and sells over 2,300 types of antibodies, kits and reagents. Much of the focus is in the areas of Apoptosis, Signal Transduction, Cell Proliferation and Heat Shock Proteins, plus many other areas of cell biology.

If you are having difficulty downloading product data or require further information, please contact us.